CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production - Wikidata - wikimedia - TriplyDB

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

http://www.wikidata.org/entity/Q29619536

about

Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation The PD-1 pathway in tolerance and autoimmunity Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura Human T regulatory cell therapy: take a billion or so and call me in the morning T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance Molecular mechanisms for adaptive tolerance and other T cell anergy models Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma A paragon of self-tolerance: CD25+CD4+ regulatory T cells and the control of immune responses HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells The quantal theory of how the immune system discriminates between "self and non-self"Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice T-cell-mediated control of autoimmunity T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease.Regulatory T cells in rheumatoid arthritis.Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units Stress-Related Immune Markers in Depression: Implications for Treatment Promises and paradoxes of regulatory T cells in inflammatory bowel disease Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Regulation generation: the suppressive functions of human regulatory T cells T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease Metabolic regulation of regulatory T cell development and function Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs Trauma equals danger--damage control by the immune system To drive or be driven: the path of a mouse model of recurrent pregnancy loss Antibody-based immunotherapy for ovarian cancer: where are we at?

P2860

Q21131435-F3372B93-E6F8-4DA2-80C9-5230AB88F298 Q21562362-EDDA6593-30F1-4FD8-810A-5E961D6D1BE2 Q24302386-7135057F-FBC4-422C-A131-3D06D6CCB0D2 Q24538658-4E219A38-E497-498D-969D-F033A83C8128 Q24539880-843765F2-51DA-4680-A002-4BB1A3E925A4 Q24540429-7A755E77-D890-4219-95BD-A42DB402F869 Q24550711-7BE39488-8DA1-41EA-8161-241B4FF21806 Q24598725-9FF753C1-F285-43E5-AB32-560DF19403E5 Q24633549-EB0C3929-8D3D-4522-A926-884560578A24 Q24645016-C2AB4A7D-8516-4E1E-BD96-287BD7095F67 Q24656069-B3032045-2F1C-4267-9233-D907EA67AD0B Q24656282-3C0C97CA-7C74-4C1E-A0F6-598D84B31296 Q24671646-505888C4-D578-4808-AAE0-0CA95E953FA8 Q24672849-8013A919-9A7B-44D1-B96E-984883ED228E Q24673863-499E8CA2-7AC8-46A9-8156-A82BF8225D77 Q24676080-940957C2-8F28-41D8-A05D-354B5A741BBD Q24679736-BC09C893-141F-4EB8-A0FD-C59B29C3EF1D Q24793306-9B46B476-0217-45A8-8EDF-26FFD7E21CEC Q24802813-B13EE231-67EA-4BD7-975F-23A9DD958D67 Q24803143-5BEC4F7B-18AB-48F0-8F9B-587AC2CF165D Q24804229-6511CF22-F5CF-41F1-B1CA-DCC616C6EE29 Q24805327-EAE3B449-97D3-4A60-8305-E127A56C892D Q24805370-5F77307F-12E5-4297-AEB2-B2B47F226627 Q24805470-5DAF2F72-8E07-4C4A-BB63-CB646DA0B604 Q24816789-D18F0ABD-B01D-4137-81D2-5CED5F6C9A25 Q24816793-3B805982-39CB-49A1-94BA-DA39C447D6D4 Q25255561-5454E606-698C-46F3-8BA7-EE700229936C Q26744624-C4FE6A78-CE94-4D74-99AB-8EE642CBBC6A Q26744973-C438541E-8E85-482C-8CCD-527A7EBC2F96 Q26771607-53ECFA13-72B8-4C32-A57C-120E5572E4A2 Q26777557-230B1797-E4AA-4747-A269-776B192B696A Q26779184-199E26BC-AB59-40DD-A243-44AC8C2FC613 Q26823216-3CEA418D-FC40-43DB-B6FB-3E3970A8E1F2 Q26823613-F10C8E28-2ACD-407A-8E36-DC12E4071673 Q26827787-EF512066-B1CF-45B4-8E65-25C620E662CB Q26852681-C8D87A72-0F54-494E-8E3F-CD681B0F9943 Q26853599-698FB70D-9E44-44AB-AAE0-8BA0E9B144FE Q26860731-EE00BE66-3014-47AB-B2E5-5BEA749CACE8 Q26866038-209D7688-B394-4BAC-8877-CE69C91190A3 Q27000514-13FF18CD-7762-4C27-8E9B-01ED51D0B0BF

P2860

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

http://www.wikidata.org/entity/Q29619536

description

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 1998

@ast

im Juli 1998 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 20 July 1998)

@en

wetenschappelijk artikel (gepubliceerd op 1998/07/20)

@nl

наукова стаття, опублікована в липні 1998

@uk

مقالة علمية (نشرت في 20-7-1998)

@ar

name

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@ast

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@en

type

label

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@ast

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@en

prefLabel

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@ast

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@en

P1433

Q29619536-907E226A-EF17-4F14-B390-1125625D0B25

P1476

Q29619536-8C594D16-F54A-4A71-B16B-C0D440976591

P2093

Q29619536-41A01585-F0B9-4D0B-984F-A6BFECB49751

Q29619536-B1574266-B97B-424B-8FBA-5D3035353BC8

P2860

Q29619536-143D30BB-3084-4EA7-97BC-38373261707F

Q29619536-1469FB9C-73CF-4251-A5EF-AC8C5C9657C8

Q29619536-17ECF298-EE4E-4918-80FB-85D3C517B2DE

Q29619536-1EDF769C-D2C9-4F58-A5B4-302AB172B31A

Q29619536-314525F2-0DD2-42F9-A519-0201179A7414

Q29619536-43015C29-7AC0-49DB-AA92-CCF0858B5F86

Q29619536-56A63841-90F3-42D5-AF5C-8358DD31D3FA

Q29619536-68A0BB2A-1CD6-441E-8864-8A6CA43D35E6

Q29619536-6C30A41B-D801-4840-9985-FDA7F43A17C0

Q29619536-6EAFA05F-E48C-4C72-9223-2FC4229EB8DD

P304

Q29619536-62C7D32C-7956-439D-A85E-3D2399F8EC3A

P31

Q29619536-D9767524-B85F-444C-A7B5-0CAB5C09706E

P3181

Q29619536-B6052841-9957-43AA-83A7-86F9D9C23D14

P356

Q29619536-10E1FBE3-6E8F-4F4E-AA95-D61185C5E557

P407

Q29619536-72800B94-27C6-45B2-B350-17EA2B716407

P433

Q29619536-50F2EE81-EF74-4EAA-89E1-A5D5E6EA50E9

P478

Q29619536-18754C2D-110B-4122-B11E-A8476BB9AB5D

P577

Q29619536-B172789E-DD10-4E69-A5E2-2B14DA335499

P5875

Q29619536-1CEDE20C-8771-4949-89C0-E0DC1FF68002

P698

Q29619536-18EBA365-BC6C-4365-8591-69235D9B5801

P921

Q29619536-92cb7ee0-2f5d-4bab-bf5a-3d8019833f99

P932

Q29619536-25A886E9-0566-41FB-91E7-0DD258300ACD

P3181

P356

P1433

Journal of Experimental Medicine

P1476

CD4+CD25+ immunoregulatory T c ...... iting interleukin 2 production

@en

P2093

Shevach EM

http://www.w3.org/2001/XMLSchema#string

Thornton AM

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients

A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

CTLA-4 can function as a negative regulator of T cell activation

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells

Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells.

P304

287-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

211497

http://www.w3.org/2001/XMLSchema#string

P356

10.1084/JEM.188.2.287

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13615013

http://www.w3.org/2001/XMLSchema#string

P698

9670041

http://www.w3.org/2001/XMLSchema#string

P921

P932

2212461

http://www.w3.org/2001/XMLSchema#string